Bibliografia UJ CM



Zapytanie: SKOLNICK PHIL
Liczba odnalezionych rekordów: 16



Przejście do opcji zmiany formatu | Wyświetl/ukryj etykiety | Wersja do druku | | | Nowe wyszukiwanie
1/16
Piotr Popik, Malgorzata Holuj, Agnieszka Nikiforuk, Tomasz Kos, Ramon Trullas, Phil Skolnick.
1-Aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats.
Psychopharmacology
2015 : Vol. 232, nr 6, s. 1025-1038, il., bibliogr., abstr.
p-ISSN: 0033-3158
AZ
ORG
AIF
IF: 3.540
Streszczenie w PubMed:
2/16
Phil Skolnick, Tomasz Kos, Janusz Czekaj, Piotr Popik.
Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test.
Acta Neuropsychiatrica
2015 : Vol. 27, nr 4, s. 228-234, il., bibliogr. 50 poz.
Copyright Scandinavian College of Neuropsychopharmacology 2015.
p-ISSN: 1601-5215
AZ
ORG
AIF
IF: 0.760
Streszczenie w PubMed:
3/16
Andrzej Pilc, Joanna M. Wierońska, Phil Skolnick.
Glutamate-based antidepressants: preclinical psychopharmacology.
Biol. Psychiatry
2013 : Vol. 73, nr 12, s. 1125-1132, il., bibliogr. 100 poz., abstr.
p-ISSN: 0006-3223
AZ
POG
AIF
IF: 9.472
4/16
Phil Skolnick, Piotr Popik, Ramon Trullas.
N-methyl-d-aspartate (NMDA) antagonists for the treatment of depression.
W: Glutamate-based therapies for psychiatric disorders.
d. Phil Skolnick
Basel : Springer, cop. 2010
s. 1-20
Milestones in Drug Therapy
p-ISBN: 978-3-0346-0240-2
RMZ
ORG
RMZ
5/16
Phil Skolnick, Piotr Popik, Ramon Trullas.
Glutamate-based antidepressants : 20 years on.
Trends in Pharmacological Sciences
2009 : Vol. 30, nr 11, s. 564-570, il., bibliogr. 78 poz.
p-ISSN: 0165-6147
AZ
POG
AIF
IF: 9.064
6/16
Anthony S. Basile, Aaron Janowsky, Krystyna Golembiowska, Magdalena Kowalska, Eyal Tam, Morris Benveniste, Piotr Popik, Agnieszka Nikiforuk, Martyna Krawczyk, Gabriel Nowak, Philip A. Krieter, Arnold S. Lippa, Phil Skolnick, Elena Koustova.
Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain.
Journal of Pharmacology and Experimental Therapeutics
2007 : Vol. 321, nr 3, s. 1208-1225, il., bibliogr., abstr.
p-ISSN: 0022-3565
AZ
ORG
AIF
IF: 4.003
Adres url:
7/16
Piotr Popik, Martyna Krawczyk, Krystyna Golembiowska, Gabriel Nowak, Aaron Janowsky, Phil Skolnica, Arnold Lippa, Anthony S. Basile.
Pharmacological profile of the "Triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677.
Cell. Mol. Neurobiol.
2006 : Vol. 26, nr 4-6, s. 857-873, il., bibliogr. 44 poz., abstr.
AZ
ORG
AIF
IF: 2.219
8/16
Phil Skolnick, Philip Krieter, Joseph Tizzano, Anthony Basile, Piotr Popik, Pal Czobor, Arnold Lippa.
Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor.
CNS Drug Reviews
2006 : Vol. 12, nr 2, s. 123-134, il., bibliogr. 29 poz., abstr.
p-ISSN: 1080-563X
AZ
POG
AIF
IF: 3.474
9/16
Phil Skolnick, Piotr Popik, Aaron Janowsky, Bernard Beer, Arnold S. Lippa.
"Broad spectrum" antidepressants: is more better for the treatment of depression?
Life Sciences
2003 : Vol. 73, nr 25, s. 3175-3179, il., bibliogr., abstr.
p-ISSN: 0024-3205
AZ
POG
AIF
IF: 1.944
10/16
Phil Skolnick, Piotr Popik, Aaron Janowsky, Bernard Beer, Arnold S. Lippa.
Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor.
European Journal of Pharmacology
2003 : Vol. 461, nr 2-3, s. 99-104, il., bibliogr., abstr.
p-ISSN: 0014-2999
AZ
ORG
AIF
IF: 2.352
Adres url:
11/16
Gabriel Nowak, Beata Legutko, Phil Skolnick, Piotr Popik.
Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors.
European Journal of Pharmacology
1998 : Vol. 342, nr 2-3, s. 367-370, il., bibliogr., abstr.
p-ISSN: 0014-2999
AZ
ORG
AIF
IF: 1.992
12/16
Anita H. Lewin, Guobin Sun, Louise Fudala, Hernan Navarro, Li-Ming Zhou, Piotr Popik, Alexander Faynsteyn, Phil Skolnick.
Molecular features associated with polyamine modulation of NMDA receptors.
Journal of Medicinal Chemistry
1998 : Vol. 41, nr 6, s. 988-995, il., bibliogr. 24 poz.
p-ISSN: 0022-2623
AZ
ORG
AIF
IF: 3.739
13/16
Piotr Popik, Phil Skolnick.
The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.
Pharmacology, Biochemistry and Behavior
1996 : Vol. 53, nr 4, s. 791-797, il., bibliogr. 57 poz.
p-ISSN: 0091-3057
AZ
ORG
AIF
IF: 1.494
BB: Medline
Medline
14/16
Richard T. Layer, Piotr Popik, Tia Olds, Phil Skolnick.
Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715).
Pharmacology, Biochemistry and Behavior
1995 : Vol. 52, nr 3, s. 621-627, il., bibliogr. 52 poz.
p-ISSN: 0091-3057
AZ
ORG
AIF
IF: 1.529
BB: Medline
Medline
15/16
Piotr Popik, Richard T. Layer, Phil Skolnick.
The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex.
Psychopharmacology
1994 : Vol. 114, nr 4, s. 672-674, il., bibliogr., abstr.
p-ISSN: 0033-3158
AZ
ORG
AIF
IF: 2.549
16/16
Gabriel Nowak, Ian A. Paul, Piotr Popik, Andrew Young, Phil Skolnick.
Ca2+ antagonists effect an antidepressant-like adaptation of the NMDA receptor complex.
European Journal of Pharmacology
1993 : Vol. 247, nr 1, s. 101-102
p-ISSN: 0014-2999
AZ
ORG
AIF
IF: 2.849
DOI:
  Wyświetl ponownie stosując format:
Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ